Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
Clinical trial NCT05060315 · TERMINATED
Trial details
- NCT number
- NCT05060315
- Sponsor
- United Therapeutics
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-05
- Primary completion
- 2024-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.